Kristin D. Alfaro-Munoz

Nov 4, 2024 | digitalcommons.library.tmc.edu | Ashwathy Balachandran Pillai |Mahmoud Yousef |Abdelrahman M. Yousef |Kristin D. Alfaro-Munoz

Objectives: Acinar cell carcinoma (ACC) accounts for about 1% of pancreatic cancers. The molecular and clinical features of ACC are less characterized than those of pancreatic ductal adenocarcinoma. Methods: We retrospectively evaluated the clinical and molecular features of ACC patients who underwent germline and/or somatic molecular testing at The University of Texas MD Anderson Cancer Center from 2008 to 2022 and two cases from 2023-2024 who underwent RNA and TME analysis by Boston Gene.

Oct 9, 2024 | mdpi.com | Ashwathy Balachandran Pillai |Mahmoud Yousef |Abdelrahman M. Yousef |Kristin D. Alfaro-Munoz

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.